TARRYTOWN, N.Y.--(BUSINESS WIRE)--Sep. 23, 2013--
Fortune® has named Prestige Brands Holdings, Inc. (NYSE-PBH) as one of
its 100 fastest growing companies. Listed as #60, PBH markets and
distributes brand name over-the-counter healthcare products throughout
the U.S., Canada, and in certain international markets.
The Fortune list measures companies by growth in revenue, profit and
stock price over the past three years. Prestige’s strong financial
performance included a 30% revenue growth, 30% adjusted EPS growth and
60% total return for the three-year period.
“Our strategy for creating shareholder value has three prongs which work
in tandem: invest in and grow our core over-the-counter healthcare
brands, harness our financial profile and industry-leading free cash
flow to pay down debt and build M&A capacity, and remain aggressive and
disciplined in the M&A market,” said Matthew M. Mannelly, CEO. “The
successful execution of this strategy worked to create the results for
which we are recognized on this important Fortune list,” he said.
Prestige Brands is the largest independent publicly-traded OTC products
company in America. The company’s core brands include Chloraseptic®
sore throat treatments, Clear Eyes® eye care products,
Compound W® wart treatments, Little Remedies® and
PediaCare® pediatric over-the-counter healthcare products,
The Doctor’s® NightGuard® dental protector, Efferdent®
denture care products, Luden’s® throat drops, Dramamine®
motion sickness treatment, BC® and Goody’s®
headache remedies, Beano® gas prevention, Debrox®
earwax remover, and in Canada, Gaviscon® antacid. (Fortune is
a registered trademark of Time Inc.)
Source: Prestige Brands Holdings, Inc.
Prestige Brands Holdings, Inc.
Dean Siegal, 914-524-6819
